The global poultry diagnostics demand is subjected to record a CAGR of 10.5%. The market revenue is likely to be valued at US$ 590 million in 2023 and exhibit a revenue growth of US$ 1.6 billion by 2033.
Global Trends & Opportunities Revamping the Poultry Diagnostics Market
Key players concentrate on scientific and technical services for the food, agricultural, and veterinary industries. They specialize in serologic diagnostic services for the poultry business. They further broaden their reach by providing diagnostic services to enterprises that produce animals for human consumption. These industries include the bovine, porcine, shrimp, and tilapia sectors. In addition, they provide training and microbiological testing services to the food and agroindustry in general. They bring together the finest from sample preparation to identification, for infections, quality indicators, food fraud, and more, with proven solutions for every stage of the test workflow.
End users can select between manual and automated solutions that are designed to produce accurate results and maximize efficiency, thus boosting the demand. Key businesses additionally provide effective testing methodologies and cutting-edge technology for the current epidemics. End users may obtain recent lessons learned on addressing the present supply chain crisis from important thought leaders. Furthermore, companies can gain an efficient and cost-effective method of scaling up testing to meet the problems given by rapid outbreaks. Therefore, these developments are helping the market to prosper.
Veterinarians may reliably obtain full diagnostic insights anytime, anywhere, thanks to artificial intelligence (AI) algorithms that provide cost-effective access to expert-level results, remote veterinary specialist evaluation, and post-diagnostic consultations. The unique combination of goods and services given by key stakeholders provides a more comprehensive picture, allowing veterinarians to make faster, more educated medical decisions for more tailored treatment. Additionally, significant businesses concentrate their innovation on identifying and developing the integrated solutions that their veterinarian and livestock producer clients require in order to flourish, thus benefiting the market.
Their portfolio contributes to the spectrum of care for predicting, preventing, detecting, and treating disease in animals. They also provide a wide range of innovative testing solutions for veterinary laboratories and organizations. This is to battle influenza A in poultry in the midst of a significant outbreak, particularly in Europe and Asia Pacific. The emergence of the highly deadly H5N8 strain of avian influenza A has resulted in significant losses for the poultry sector, including the mortality of almost 12 million birds. The broad array of quick detection tools offered by key players includes the highly reliable, ready-to-use virotype Influenza A RT-PCR kit created by another important player which is a good sign for market growth.
Key participants desire to influence the future of poultry health via disease prevention, aiming to help win the struggle against poultry illnesses and shape the future of poultry well-being and correspondingly aid market growth. Their extensive portfolio of vaccinations and delivery devices provides unrivaled protection against a wide range of poultry health concerns. Among these are vaccinations against Marek's disease, infectious bursal disease, newcastle disease, and others. Key businesses provide existing and novel vaccines, diagnostics, research services, technological experience, and an unwavering commitment to their customer's success. As a result, they play an important role in providing safe, inexpensive, plentiful, and sustainable quality chicken meat and eggs to the world. This is providing impetus to the market for poultry diagnostics as a whole.
Attributes
Details
Poultry Diagnostics Market HCAGR (2017 to 2022)
12.2%
Poultry Diagnostics Market CAGR (2023 to 2033)
10.5%
Market Size for Poultry Diagnostics (2023)
US$ 590 million
Market Size for Poultry Diagnostics (2033)
US$ 1.6 billion
Market Size for Poultry Diagnostics - Absolute Dollar Growth
US$ 1 billion
The demand for foods high in protein has grown as people become more conscious of maintaining good health. In addition to having a high protein content, chicken products like eggs and meat also include iron, magnesium, zinc, vitamin B, and vitamin E. Therefore, it is anticipated that the market would rise in response to the rising need for productive poultry farming.
Starting this business requires between US$ 5,000 and US$ 25,000 in funding. The increased profitability of poultry farming is driving up demand for it in the market. The United States economy as a whole was US$ 35.5 billion larger in 2020 due to the production of chicken. Therefore, it is projected that improvements in science and technology, together with government backing in the form of programs like subsidies, is anticipated to spark innovations in the poultry diagnostics market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
A Contrast with the Historical Market Scenario
Research from Future Market Insights claims that the global forum for poultry diagnostics has lately experienced phenomenal growth. The leading competitors on the market have joined forces to satisfy the expanding demand for poultry diagnostics. The CAGR, which was 12.2% from 2017 to 2022, is expected to decline to 10.5% during the forecasted period.
Poultry healthcare techniques include evacuating sick birds, administering immunizations on time, managing healthcare resources, and maintaining sanitation, feeding and feed supply, housing, and other aspects of poultry management.
Primary poultry wound care can be done by thoroughly washing the wound/infected area with water, hydrogen peroxide. Vetericyn Plus Poultry Care spray is commonly used by farmers as first care. Various poultry wound care products are easily available nowadays.
The global poultry diagnostics market is being driven by rising disease outbreaks such as newcastle disease and avian influenza, besides others, and also growing demand for chicken as a food due to rising interest in poultry farming in emerging and developed countries. Avian Influenza, Avian Mycoplasmosis, Avian Salmonellosis, and Infectious Bronchitis are a few diseases that affect birds.
Eggs are widely consumed worldwide and are an important ingredient for bakery products, consumption of food products made of infected eggs can lead to food poisoning. As a result, dairy diagnostics are necessary to avoid such situations. Efficient dairy diagnostics detects problems at the initial stage and avoids any unwanted illness.
One of the significant factors responsible for the growth of the poultry diagnostics market is the rise in disease spread in poultry around the world. The introduction of animal health information portals, particularly in developed economies, as well as increased initiatives taken by respective governments and animal welfare organizations, has accelerated market expansion.
Comparative Analysis of Adjacent Markets
Poultry Diagnostics Market:
Attribute
Poultry Diagnostics Market
CAGR (2023 to 2033)
10.5%
Market Value (2033)
US$ 1.6 billion
Growth Factor
The advent of animal health information portals, particularly in developed countries, as well as an increase in government activities around the world.
Opportunity
The increase in healthcare spending, developments in healthcare infrastructure, and high disposable income collectively support the poultry diagnostics market.
Restraints
The market is expected to be hampered by high poultry production costs and a lack of animal health knowledge.
Poultry Feed Market:
Attributes
Poultry Feed Market
CAGR (2023 to 2033)
5.5%
Market Value (2033)
US$ 238.2 billion
Growth Factor
Farmers should expect increased farm profitability and productivity as they shift away from diet-based feed and toward excellent nutrition.
Opportunity
Several advanced economies are gradually transitioning to monogastric farming, with poultry and pigs accounting for various animals.
Restraints
Rising broiler supply and consumers' preference for fish and meat over poultry owing to reduced cost are predicted to stymie the market.
Poultry Farming Equipment Market:
Attributes
Poultry Farming Equipment Market
CAGR (2023 to 2033)
6%
Market Value (2033)
US$ 6,678 million
Growth Factor
Rising processed food consumption, as well as government incentives for the use of farming technology in developing countries.
Opportunity
Increasing demand for high-quality chicken products, improved efficiency, reduced carbon footprint, and advanced technology investment may collectively generate market opportunities.
Restraints
Land resource limits are a severe problem for poultry farming, inhibiting the expansion of poultry farming equipment.
Find your sweet spots for generating winning opportunities in this market.
Category-wise Insights
ELISA - By Test Type
By test type, the market is segmented into ELISA and PCR. Future Market Insights projects that the ELISA category is likely to have a sizable market share of 10.2% over the course of the projected period.
The enzyme-linked adsorption assay (ELISA) test is predicted to have a higher market share in 2023. The ELISA is the most extensively used test to detect or diagnose virus infection, particularly infection of blood-borne viruses. Its sensitivity and practicality have made it the most used first screening assay. ELISA tests are also frequently used to identify antibodies in the blood.
Infectious such as avian influenza, which is widespread in developed countries, are easily detected with ELISA. ELISA is a highly dependable and cost-effective method. This feature has increased ELISA's acceptance around the world. Diluents and buffers, which are employed in ELISA, are also less expensive than other diagnostic choices, which help to increase diagnostics demand.
Avian Influenza - By Disease
According to analysts at Future Market Insights, the avian influenza category is expected to have a sizeable market share of 9.8% over the forecast period.
Avian influenza is expected to dominate the poultry diagnostics industry. The most common pathogenic kind that infects domestic birds is avian influenza. Bird flu is another name for avian influenza. Avian influenza (AI) is a highly contagious viral infection that affects a variety of food-producing birds.
Avian influenza has been linked to respiratory illnesses, reduced egg production, and subclinical infections. A high pathogenic (HPAI) version of the virus has been reported to harm domestic flocks in a few cases. Systemic diseases and death are caused by increased pathogenic type.
Avian salmonellosis, on the other hand, is the one of the infection that causes chicken disease. Pullorum fever, paratyphoid, and poultry typhoid are all caused by Salmonella. As a result, the demand for poultry diagnostic labs grows.
Lack of Knowledge in Developing Economies & Other Hindrances and Future Prospects
Uncertainty over poultry management is anticipated to be a problem in developing nations like India and China. Lack of quick poultry test kits and a shortage of specialists in emerging markets are likely to act as restraints for the poultry diagnostics market growth.
On the contrary, both veterinary hospitals and clinics receiving government funding as well as the demand for food items generated from poultry have increased. During the projected period, these factors are likely to drive the worldwide market for poultry diagnostics.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Region-wise Insights
Country
United States
CAGR (2023 to 2033)
10.3%
HCAGR (2017 to 2022)
14.5%
Country
United Kingdom
CAGR (2023 to 2033)
9.5%
HCAGR (2017 to 2022)
13.5%
Country
China
CAGR (2023 to 2033)
9.9%
HCAGR (2017 to 2022)
14.1%
Country
Japan
CAGR (2023 to 2033)
9%
HCAGR (2017 to 2022)
12.9%
Country
South Korea
CAGR (2023 to 2033)
8.2%
HCAGR (2017 to 2022)
11.5%
Molecular Methods such as PCR and Sequencing Encouraged in the United States
Attributes
Details
United States Market Size (2033)
US$ 566.9 million
United States Market Absolute Dollar Growth (US$ million/billion)
US$ 353.7 million
The United States is the market leader in poultry diagnostics, accounting for 10.3% of total North America sales. The poultry diagnostics market in the United States is expected to reach a high of US$ 566.9 million. Various portals that supply animal health information are one reason driving market expansion. Farmers may use these portals to keep track of preventative diagnostics, missed immunizations, nutritional information, and essential diagnostic tests.
Key players in the United States urge end user to collaborate with them for precise poultry testing that is expected to create trust in them. Their cutting-edge solutions eliminate the need for extensive testing. Furthermore, they provide tested solutions that encourage decisive action. Poultry testing laboratories in the United States seek to safeguard and promote poultry health.
The Board of Animal Health is the state regulatory agency in charge of keeping farmers and industry up to date on many ongoing disease surveillance programs, as well as responding to and acting as necessary. Universities offer the necessary space, hands-on technical experience, and laboratory professionals to support poultry disease surveillance and diagnosis programs.
In the United States, molecular methods such as PCR and sequencing are encouraged. They give the most up-to-date information on a flock's health and are commonly utilized in human and veterinary diagnostics. Key players use cutting-edge products and systems to monitor and optimize poultry health. Furthermore, prior to batch release, all of their assays are subjected to stringent validation processes. Furthermore, they provide 'software store' results as well as flock/herd information in an online database. This enables users to effectively manage poultry diagnostics.
Researchers in the United Kingdom Develop Methods to Assess Immune Responses
Attributes
Details
United Kingdom Market Size (2033)
US$ 67.3 million
United Kingdom Market Absolute Dollar Growth (US$ million/billion)
US$ 40.3 million
The United Kingdom is a substantial poultry diagnostics market, with an estimated value of US$ 67.3 million and a revenue growth rate of 9.5% during the forecast period. The rise in zoonotic illnesses is a significant factor driving market expansion. Furthermore, significant businesses provide poultry diagnostic kits that yield high-quality, dependable findings. This allows for the low-cost identification of a wide range of diseases such as IBD, IBV, NDV, and AIV.
Researchers developed numerous methods and procedures to assess the breadth of immune responses elicited by vaccinations against several forms of the infectious bursal disease virus (IBDV). Vaccination is the primary technique of disease prevention in poultry. However, diverse strains of IBDV are spreading around the world. As a result, key players are motivated to establish if vaccination against one strain might elicit an immune response against other viral types. Ultimately, they want to know how many distinct versions a vaccination can protect against.
Many sections of the poultry business benefit from key companies' veterinary consulting and diagnostic services. They are essentially poultry doctors who provide a comprehensive variety of veterinary services such as quick access telephone counselling, rapid post-mortem examination, disease control health planning, and so on. Furthermore, they provide extensive online training in a variety of therapeutic areas to assist veterinary doctors in managing illnesses and using goods as safely and efficiently as possible.
China’s expanding Demand has Resulted in an Increase in Antibiotic Usage
Attributes
Details
China Market Size (2033)
US$ 114.8 million
China Market Absolute Dollar Growth (US$ million/billion)
US$ 70 million
China is a lucrative poultry diagnostics market, with a revenue growth rate of 9.9% and a forecasted value of US$ 114.8 million during the forecast year. Increased government and animal welfare operations in the country to raise awareness about poultry illnesses are also helping to expand the industry. Moreover, rising zoonotic disease prevalence and increasing avian diseases are expected to drive market growth throughout the forecast period.
The massive expansion in chicken production to serve China's expanding demand has resulted in an increase in antibiotic usage. This resulted in an alarming cases of antibiotic resistance (ABR) detected in animals and, as a result, people, through direct contact, environmental pollution, and food intake. Therefore, machine learning is expected to be used by key stakeholders to uncover new techniques to identify and target sickness in Chinese poultry farms. This lessens the requirement for antibiotic therapy while also lowering the likelihood of antibiotic resistance spreading to human populations.
New diagnostics are predicted to provide huge benefits to broiler farmers and may represent the key to more successful bird management. Key participants argue that poultry serum tests and causer tests, in addition to periodic monitoring and data collection management, are required to diagnose poultry illnesses. Their poultry test devices work well in terms of complete chicken serum profile management. It also has high dependability and data compatibility.
In Japan, Key Players Examine Illness Circumstances, Distribution Patterns, and Economic Designs
Attributes
Details
Japan Market Size (2033)
US$ 93.8 million
Japan Market Absolute Dollar Growth (US$ million/billion)
US$ 54.1 million
Japan is an important poultry diagnostics market, representing 9% of overall sales. The Japanese poultry diagnostics market is estimated to be worth US$ 93.8 million. In order to enhance poultry health in Japan, leading physicians use new technology to offer diagnostic services. In response to requests from Japan's central and municipal governments, they may detect unusual ailments, including exotic diseases.
In Japan, key businesses manufacture diagnostic agents, vaccinations, and other medications that are essential for the protection of agricultural stock against infectious illnesses. Furthermore, they principally offer these biologicals to organizations in charge of disease prevention and control, as well as animal quarantine throughout the nation. In addition, they examine illness circumstances, distribution patterns, and economic damages using epidemiological methodologies. Their study is to identify risk factors for disease outbreaks and to develop effective control and prevention methods.
Since the 20th century, several farms in Japan has declined while the poultry population has expanded. This indicates that farms have gotten more technologically advanced and have chosen intense and efficient production methods. Furthermore, effective poultry practices have produced seasonal and national consumption-based poultry productivity intervals. This has resulted in a rise in demand for poultry diagnostics in the country, resulting in varied market opportunities.
Newbies are Catching up with Key Players with Innovative Strategies: Start-up Sphere
Start-up companies are introducing advanced technologies and services to contribute to the global poultry diagnostics market growth:
EIO Diagnostics - It has designed an integrated system that includes a portable device and software for continuous and individual monitoring of farmed animals in order to detect disease early. Rather than depending on the internal temperature of bovines to identify fever and infection, the business says that its system monitors the udder (without physical touch) for early-stage inflammatory reactions, and its proprietary algorithm alerts the livestock farmer of the possible illness. As of September 2017, the business is conducting real-time experiments to monitor chicken flock health and identify individuals with early indications of sickness.
VaxAlta - It has developed innovative glycoconjugate vaccines for farm animals. The firm creates vaccinations that reduce the need for antibiotics while also enhancing animal health and protecting them from infections such as bacteria, viruses, and parasites. It also creates testing platforms using antibodies that are specific to the glycan antigen. It's also utilized as a diagnostic platform.
Top Companies Transforming the Poultry Diagnostics Market Space
The poultry diagnostics market is very competitive due to the existence of several established rivals. In order to capitalize on market growth potential, these companies are concentrating on expanding their reach through acquisitions, expansions, product approvals, and launches.
Recent Developments:
In February 2018, Avian Influenza H5-H7-H9 Multiplex, a PCR testing kit for the detection of influenza in poultry, was unveiled by BioChek.
In November 2019, by keeping track of the microbiological health of whole flocks, Evonik introduces a new service product group that enables poultry growers to increase animal output.
In April 2021, the Bristol-based biotech firm Ferryx has announced a cooperation with AB Agri, a multinational agri-food company focusing on food security and sustainability, to perform the first-ever United Kingdom chicken trials of its flagship product.
Key Market Players of the Poultry Diagnostics Market
Agrobiotek Internacional
Affinitech Ltd.
Biochek
Bioingentech Biotechnologies Inc.
Bionote Inc.
Boehringer Ingelheim GmbH
GD Animal Health
Idexx Laboratories Inc.
IDVet
Megacor Diagnostik GmbH
Qiagen N.V.
Thermo Fisher Scientific
Zoetis Inc.
Bioneer Corporation
Key Segments Profiled in the Poultry Diagnostics Market Survey
By Test Type:
ELISA Test
PCR Test
By Disease:
Avian Salmonellosis
Avian Influenza
Newcastle Disease
Avian Mycoplasmosis
Avian Pasteurellosis
Infectious Bronchitis
Infectious Bursal Disease
Avian Encephalomyelitis
Avian Reovirus
Chicken Anemia
By Services:
Bacteriology
Virology
Parasitology
By Region:
North America
Latin America
Asia Pacific
The Middle East & Africa
Europe
Frequently Asked Questions
What is the Current Poultry Diagnostics Market Valuation?
The Poultry Diagnostics Market is pegged at a value of US$ 590 million in 2023.
What is the Projected Size of the Poultry Diagnostics Market by 2033?
The Poultry Diagnostics Market is estimated to reach US$ 1.6 billion by 2033.
What is the projected CAGR for the Poultry Diagnostics Market?
Sales of fine hydrates are anticipated to surge at a noteworthy CAGR of 10.5% through 2033.
Which Country Demonstrates Significant Profit Potential for Poultry Diagnostics?
The market for poultry diagnostics is thriving in China thanks to the country's large poultry population, rising meat consumption, and government support.
How was the Historical Performance of the Poultry Diagnostics Market?
In 2022, the Poultry Diagnostics Market reached a value CAGR of 12.2%.
Table of Content
1. Executive Summary | Poultry Diagnostics Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Test, 2017 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test, 2023 to 2033
5.3.1. ELISA Test
5.3.2. PCR Test
5.4. Y-o-Y Growth Trend Analysis By Test, 2017 to 2022
5.5. Absolute $ Opportunity Analysis By Test, 2023 to 2033
6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Disease
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Disease, 2017 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease, 2023 to 2033
6.3.1. Avian Salmonellosis
6.3.2. Avian Influenza
6.3.3. Newcastle Disease
6.3.4. Avian Mycoplasmosis
6.3.5. Avian Pasteurellosis
6.3.6. Infectious Bronchitis
6.3.7. Infectious Bursal Disease
6.3.8. Avian Encephalomyelitis
6.3.9. Avian Reovirus
6.3.10. Chicken Anemia
6.4. Y-o-Y Growth Trend Analysis By Disease, 2017 to 2022
6.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033
7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Service
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Service , 2017 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service , 2023 to 2033
7.3.1. Bacteriology
7.3.2. Virology
7.3.3. Parasitology
7.4. Y-o-Y Growth Trend Analysis By Service , 2017 to 2022
7.5. Absolute $ Opportunity Analysis By Service , 2023 to 2033
8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Test
9.2.3. By Disease
9.2.4. By Service
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Test
9.3.3. By Disease
9.3.4. By Service
9.4. Key Takeaways
10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Rest of Latin America
10.2.2. By Test
10.2.3. By Disease
10.2.4. By Service
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Test
10.3.3. By Disease
10.3.4. By Service
10.4. Key Takeaways
11. Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. United kingdom
11.2.1.5. Spain
11.2.1.6. BENELUX
11.2.1.7. Russia
11.2.1.8. Rest of Europe
11.2.2. By Test
11.2.3. By Disease
11.2.4. By Service
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Test
11.3.3. By Disease
11.3.4. By Service
11.4. Key Takeaways
12. East Asia Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Test
12.2.3. By Disease
12.2.4. By Service
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Test
12.3.3. By Disease
12.3.4. By Service
12.4. Key Takeaways
13. South Asia Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Rest of South Asia
13.2.2. By Test
13.2.3. By Disease
13.2.4. By Service
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Test
13.3.3. By Disease
13.3.4. By Service
13.4. Key Takeaways
14. Oceania Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Test
14.2.3. By Disease
14.2.4. By Service
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Test
14.3.3. By Disease
14.3.4. By Service
14.4. Key Takeaways
15. Middle East and Africa Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. Türkiye
15.2.1.3. South Africa
15.2.1.4. Rest of Middle East and Africa
15.2.2. By Test
15.2.3. By Disease
15.2.4. By Service
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Test
15.3.3. By Disease
15.3.4. By Service
15.4. Key Takeaways
16. Key Countries Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Test
16.1.2.2. By Disease
16.1.2.3. By Service
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Test
16.2.2.2. By Disease
16.2.2.3. By Service
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Test
16.3.2.2. By Disease
16.3.2.3. By Service
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Test
16.4.2.2. By Disease
16.4.2.3. By Service
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Test
16.5.2.2. By Disease
16.5.2.3. By Service
16.6. Germany
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Test
16.6.2.2. By Disease
16.6.2.3. By Service
16.7. Italy
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Test
16.7.2.2. By Disease
16.7.2.3. By Service
16.8. France
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Test
16.8.2.2. By Disease
16.8.2.3. By Service
16.9. United kingdom
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Test
16.9.2.2. By Disease
16.9.2.3. By Service
16.10. Spain
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Test
16.10.2.2. By Disease
16.10.2.3. By Service
16.11. BENELUX
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Test
16.11.2.2. By Disease
16.11.2.3. By Service
16.12. Russia
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Test
16.12.2.2. By Disease
16.12.2.3. By Service
16.13. China
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Test
16.13.2.2. By Disease
16.13.2.3. By Service
16.14. Japan
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Test
16.14.2.2. By Disease
16.14.2.3. By Service
16.15. South Korea
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Test
16.15.2.2. By Disease
16.15.2.3. By Service
16.16. India
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Test
16.16.2.2. By Disease
16.16.2.3. By Service
16.17. Thailand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Test
16.17.2.2. By Disease
16.17.2.3. By Service
16.18. Indonesia
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Test
16.18.2.2. By Disease
16.18.2.3. By Service
16.19. Malaysia
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Test
16.19.2.2. By Disease
16.19.2.3. By Service
16.20. Australia
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Test
16.20.2.2. By Disease
16.20.2.3. By Service
16.21. New Zealand
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Test
16.21.2.2. By Disease
16.21.2.3. By Service
16.22. GCC Countries
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Test
16.22.2.2. By Disease
16.22.2.3. By Service
16.23. Türkiye
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Test
16.23.2.2. By Disease
16.23.2.3. By Service
16.24. South Africa
16.24.1. Pricing Analysis
16.24.2. Market Share Analysis, 2022
16.24.2.1. By Test
16.24.2.2. By Disease
16.24.2.3. By Service
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Test
17.3.3. By Disease
17.3.4. By Service
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Agrobiotek Internacional
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Affinitech Ltd.
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Biochek
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Bioingentech Biotechnologies Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Bionote Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Boehringer Ingelheim GmbH
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. GD Animal Health
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Idexx Laboratories Inc.
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. IDVet
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Megacor Diagnostik GmbH
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Qiagen N.V.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Thermo Fisher Scientific
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Zoetis Inc.
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. Bioneer Corporation
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2017 to 2033
Table 2: Global Value (US$ Million) Forecast by Test, 2017 to 2033
Table 3: Global Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 4: Global Value (US$ Million) Forecast by Service , 2017 to 2033
Table 5: North America Value (US$ Million) Forecast by Country, 2017 to 2033
Table 6: North America Value (US$ Million) Forecast by Test, 2017 to 2033
Table 7: North America Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 8: North America Value (US$ Million) Forecast by Service , 2017 to 2033
Table 9: Latin America Value (US$ Million) Forecast by Country, 2017 to 2033
Table 10: Latin America Value (US$ Million) Forecast by Test, 2017 to 2033
Table 11: Latin America Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 12: Latin America Value (US$ Million) Forecast by Service , 2017 to 2033
Table 13: Europe Value (US$ Million) Forecast by Country, 2017 to 2033
Table 14: Europe Value (US$ Million) Forecast by Test, 2017 to 2033
Table 15: Europe Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 16: Europe Value (US$ Million) Forecast by Service , 2017 to 2033
Table 17: East Asia Value (US$ Million) Forecast by Country, 2017 to 2033
Table 18: East Asia Value (US$ Million) Forecast by Test, 2017 to 2033
Table 19: East Asia Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 20: East Asia Value (US$ Million) Forecast by Service , 2017 to 2033
Table 21: South Asia Value (US$ Million) Forecast by Country, 2017 to 2033
Table 22: South Asia Value (US$ Million) Forecast by Test, 2017 to 2033
Table 23: South Asia Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 24: South Asia Value (US$ Million) Forecast by Service , 2017 to 2033
Table 25: Oceania Value (US$ Million) Forecast by Country, 2017 to 2033
Table 26: Oceania Value (US$ Million) Forecast by Test, 2017 to 2033
Table 27: Oceania Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 28: Oceania Value (US$ Million) Forecast by Service , 2017 to 2033
Table 29: Middle East and Africa Value (US$ Million) Forecast by Country, 2017 to 2033
Table 30: Middle East and Africa Value (US$ Million) Forecast by Test, 2017 to 2033
Table 31: Middle East and Africa Value (US$ Million) Forecast by Disease, 2017 to 2033
Table 32: Middle East and Africa Value (US$ Million) Forecast by Service , 2017 to 2033
List of Charts
Figure 1: Global Value (US$ Million) by Test, 2023 to 2033
Figure 2: Global Value (US$ Million) by Disease, 2023 to 2033
Figure 3: Global Value (US$ Million) by Service , 2023 to 2033
Figure 4: Global Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Value (US$ Million) Analysis by Region, 2017 to 2033
Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 9: Global Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 10: Global Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 11: Global Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 12: Global Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 13: Global Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 14: Global Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 15: Global Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 16: Global Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 17: Global Attractiveness by Test, 2023 to 2033
Figure 18: Global Attractiveness by Disease, 2023 to 2033
Figure 19: Global Attractiveness by Service , 2023 to 2033
Figure 20: Global Attractiveness by Region, 2023 to 2033
Figure 21: North America Value (US$ Million) by Test, 2023 to 2033
Figure 22: North America Value (US$ Million) by Disease, 2023 to 2033
Figure 23: North America Value (US$ Million) by Service , 2023 to 2033
Figure 24: North America Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 26: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 29: North America Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 30: North America Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 31: North America Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 32: North America Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 33: North America Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 34: North America Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 35: North America Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 36: North America Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 37: North America Attractiveness by Test, 2023 to 2033
Figure 38: North America Attractiveness by Disease, 2023 to 2033
Figure 39: North America Attractiveness by Service , 2023 to 2033
Figure 40: North America Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Value (US$ Million) by Test, 2023 to 2033
Figure 42: Latin America Value (US$ Million) by Disease, 2023 to 2033
Figure 43: Latin America Value (US$ Million) by Service , 2023 to 2033
Figure 44: Latin America Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 46: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 49: Latin America Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 50: Latin America Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 51: Latin America Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 52: Latin America Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 53: Latin America Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 54: Latin America Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 55: Latin America Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 56: Latin America Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 57: Latin America Attractiveness by Test, 2023 to 2033
Figure 58: Latin America Attractiveness by Disease, 2023 to 2033
Figure 59: Latin America Attractiveness by Service , 2023 to 2033
Figure 60: Latin America Attractiveness by Country, 2023 to 2033
Figure 61: Europe Value (US$ Million) by Test, 2023 to 2033
Figure 62: Europe Value (US$ Million) by Disease, 2023 to 2033
Figure 63: Europe Value (US$ Million) by Service , 2023 to 2033
Figure 64: Europe Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 66: Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 69: Europe Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 70: Europe Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 71: Europe Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 72: Europe Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 73: Europe Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 74: Europe Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 75: Europe Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 76: Europe Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 77: Europe Attractiveness by Test, 2023 to 2033
Figure 78: Europe Attractiveness by Disease, 2023 to 2033
Figure 79: Europe Attractiveness by Service , 2023 to 2033
Figure 80: Europe Attractiveness by Country, 2023 to 2033
Figure 81: East Asia Value (US$ Million) by Test, 2023 to 2033
Figure 82: East Asia Value (US$ Million) by Disease, 2023 to 2033
Figure 83: East Asia Value (US$ Million) by Service , 2023 to 2033
Figure 84: East Asia Value (US$ Million) by Country, 2023 to 2033
Figure 85: East Asia Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 86: East Asia Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: East Asia Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: East Asia Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 89: East Asia Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 90: East Asia Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 91: East Asia Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 92: East Asia Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 93: East Asia Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 94: East Asia Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 95: East Asia Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 96: East Asia Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 97: East Asia Attractiveness by Test, 2023 to 2033
Figure 98: East Asia Attractiveness by Disease, 2023 to 2033
Figure 99: East Asia Attractiveness by Service , 2023 to 2033
Figure 100: East Asia Attractiveness by Country, 2023 to 2033
Figure 101: South Asia Value (US$ Million) by Test, 2023 to 2033
Figure 102: South Asia Value (US$ Million) by Disease, 2023 to 2033
Figure 103: South Asia Value (US$ Million) by Service , 2023 to 2033
Figure 104: South Asia Value (US$ Million) by Country, 2023 to 2033
Figure 105: South Asia Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 106: South Asia Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: South Asia Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: South Asia Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 109: South Asia Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 110: South Asia Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 111: South Asia Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 112: South Asia Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 113: South Asia Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 114: South Asia Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 115: South Asia Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 116: South Asia Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 117: South Asia Attractiveness by Test, 2023 to 2033
Figure 118: South Asia Attractiveness by Disease, 2023 to 2033
Figure 119: South Asia Attractiveness by Service , 2023 to 2033
Figure 120: South Asia Attractiveness by Country, 2023 to 2033
Figure 121: Oceania Value (US$ Million) by Test, 2023 to 2033
Figure 122: Oceania Value (US$ Million) by Disease, 2023 to 2033
Figure 123: Oceania Value (US$ Million) by Service , 2023 to 2033
Figure 124: Oceania Value (US$ Million) by Country, 2023 to 2033
Figure 125: Oceania Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 126: Oceania Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 127: Oceania Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 128: Oceania Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 129: Oceania Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 130: Oceania Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 131: Oceania Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 132: Oceania Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 133: Oceania Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 134: Oceania Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 135: Oceania Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 136: Oceania Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 137: Oceania Attractiveness by Test, 2023 to 2033
Figure 138: Oceania Attractiveness by Disease, 2023 to 2033
Figure 139: Oceania Attractiveness by Service , 2023 to 2033
Figure 140: Oceania Attractiveness by Country, 2023 to 2033
Figure 141: Middle East and Africa Value (US$ Million) by Test, 2023 to 2033
Figure 142: Middle East and Africa Value (US$ Million) by Disease, 2023 to 2033
Figure 143: Middle East and Africa Value (US$ Million) by Service , 2023 to 2033
Figure 144: Middle East and Africa Value (US$ Million) by Country, 2023 to 2033
Figure 145: Middle East and Africa Value (US$ Million) Analysis by Country, 2017 to 2033
Figure 146: Middle East and Africa Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 147: Middle East and Africa Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 148: Middle East and Africa Value (US$ Million) Analysis by Test, 2017 to 2033
Figure 149: Middle East and Africa Value Share (%) and BPS Analysis by Test, 2023 to 2033
Figure 150: Middle East and Africa Y-o-Y Growth (%) Projections by Test, 2023 to 2033
Figure 151: Middle East and Africa Value (US$ Million) Analysis by Disease, 2017 to 2033
Figure 152: Middle East and Africa Value Share (%) and BPS Analysis by Disease, 2023 to 2033
Figure 153: Middle East and Africa Y-o-Y Growth (%) Projections by Disease, 2023 to 2033
Figure 154: Middle East and Africa Value (US$ Million) Analysis by Service , 2017 to 2033
Figure 155: Middle East and Africa Value Share (%) and BPS Analysis by Service , 2023 to 2033
Figure 156: Middle East and Africa Y-o-Y Growth (%) Projections by Service , 2023 to 2033
Figure 157: Middle East and Africa Attractiveness by Test, 2023 to 2033
Figure 158: Middle East and Africa Attractiveness by Disease, 2023 to 2033
Figure 159: Middle East and Africa Attractiveness by Service , 2023 to 2033
Figure 160: Middle East and Africa Attractiveness by Country, 2023 to 2033
